Blackstone Inc’s Zosano Pharma Corporation ZSAN Stock Holding History

Blackstone Inc’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,489	Closed	-$28K	–	299
2022 Q1	$28K	Hold	3,489	–	–	﹤0.01%	243
2021 Q4	$57K	Hold	3,489	–	–	﹤0.01%	494
2021 Q3	$88K	Buy	+3,489	New	+$90.5K	﹤0.01%	550

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Blackstone Inc's ZSAN Position: Q2 2022 in Review

Blackstone Inc sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 3,489 shares — an estimated $28K sold.

Blackstone Inc first reported a position in ZSAN in Q3 2021 and held it in 3 quarters. The position peaked at $88K in Q3 2021. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

Blackstone Inc reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
Blackstone Inc sold 3,489 Zosano Pharma Corporation shares in Q2 2022, an estimated $28K.
Blackstone Inc first reported a position in Zosano Pharma Corporation in Q3 2021 and held it in 3 quarters.
Blackstone Inc's Zosano Pharma Corporation position peaked at $88K in Q3 2021.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Blackstone Inc's 13F filing for Q2 2022, filed 15 Aug 2022.